BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021
March 29, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, March 29, 2021 (GLOBE NEWSWIRE) -- Company expands clinical footprint, installations and commercial sales with leading hospitalsNeurostimulation division to develop a novel sensing and...
BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference
March 19, 2021 12:15 ET
|
BioSig Technologies, Inc.
Westport, CT, March 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference
March 10, 2021 17:30 ET
|
BioSig Technologies, Inc.
Westport, CT, March 10, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference
March 09, 2021 16:45 ET
|
BioSig Technologies, Inc.
Westport, CT, March 09, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary
March 04, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, March 04, 2021 (GLOBE NEWSWIRE) -- The patent is exclusively licensed from Mayo Foundation for Medical Education and Research Claims address methods and materials for improving the...
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
March 03, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the...
BioSig Appoints Brenda Castrodad to Lead Human Resources
February 16, 2021 08:45 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 16, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ Systems
February 10, 2021 10:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 10, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System
February 02, 2021 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Global market for AI in healthcare is estimated to reach $45.2 billion by 2026 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the...
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
February 01, 2021 09:00 ET
|
SetPoint Medical
VALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced the enrollment...